A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.
Saved in:
| Title: | A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma. |
|---|---|
| Authors: | Turner KA; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: katherineaturner@uabmc.edu., Edwards CC; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: carsoncedwards@uabmc.edu., Ketch PW; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: pketch@uabmc.edu., Dinkins KG; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: kdkincaid@uabmc.edu., Wilbanks A; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: annaburton@uabmc.edu., Leath CA 3rd; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: cleath@uabmc.edu., Arend RC; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: rarend@uabmc.edu., Toboni MD; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: mdtoboni@uabmc.edu. |
| Source: | Gynecologic oncology [Gynecol Oncol] 2026 Jun; Vol. 209, pp. 107-110. Date of Electronic Publication: 2026 May 13. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42127734 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Turner+KA%22">Turner KA</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: katherineaturner@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Edwards+CC%22">Edwards CC</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: carsoncedwards@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Ketch+PW%22">Ketch PW</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: pketch@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Dinkins+KG%22">Dinkins KG</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: kdkincaid@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Wilbanks+A%22">Wilbanks A</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: annaburton@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Leath+CA+3rd%22">Leath CA 3rd</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: cleath@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Arend+RC%22">Arend RC</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: rarend@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Toboni+MD%22">Toboni MD</searchLink>; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: mdtoboni@uabmc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220365304%22">Gynecologic oncology</searchLink> [Gynecol Oncol] 2026 Jun; Vol. 209, pp. 107-110. <i>Date of Electronic Publication: </i>2026 May 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0365304 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-6859 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200908258%22">00908258 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42127734 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ygyno.2026.05.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107 Titles: – TitleFull: A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Turner KA – PersonEntity: Name: NameFull: Edwards CC – PersonEntity: Name: NameFull: Ketch PW – PersonEntity: Name: NameFull: Dinkins KG – PersonEntity: Name: NameFull: Wilbanks A – PersonEntity: Name: NameFull: Leath CA 3rd – PersonEntity: Name: NameFull: Arend RC – PersonEntity: Name: NameFull: Toboni MD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1095-6859 Numbering: – Type: volume Value: 209 Titles: – TitleFull: Gynecologic oncology Type: main |
| ResultId | 1 |